IRS Code 280E

IRS Confirms No Federal Tax Deductions For Marijuana Businesses Until Rescheduling Is Finalized

Post Cannabis Rescheduling: What's Next For Marijuana Giants? Potential $1.1B Cash Flow Boost From IRS 280E Removal

Beyond Amazon And Coca-Cola: Why Cannabis Is Catching Up To Blue Chip Stocks In Profitability

Post Cannabis Rescheduling: What's Next For Marijuana Giants? Potential $1.1B Cash Flow Boost From IRS 280E Removal

Beyond Amazon And Coca-Cola: Why Cannabis Is Catching Up To Blue Chip Stocks In Profitability

Financial Innovation: Creative Ways To Improve Your Cannabis Business From Experts In The Know

Is Cannabis Rescheduling A Solution? Experts Delve Into California Cannabis Retail Challenges At Benzinga Conference

Financial Innovation: Creative Ways To Improve Your Cannabis Business From Experts In The Know

Is Cannabis Rescheduling A Solution? Experts Delve Into California Cannabis Retail Challenges At Benzinga Conference

Cannabis Valuation Jumps Post-Rescheduling Recommendation, Viridian Report Reveals

Is The Cannabis Industry Too Optimistic?

IRS Code 280E Recent News

Sherrod Brown Champions Cannabis Banking Reform: A Game-Changer Set To Triumph This Fall?

The intricate web of politics, priorities and pressures in the Senate and House is set to make this fall's legislative session a captivating one. Legislative Focus

Trulieve CEO: Federal Rescheduling Could Change Heavy Tax Burden For Cannabis Industry

"It's not if, it's just when," said Kim Rivers, CEO of Trulieve Cannabis Corp (OTCQX: TCNNF), regarding the recent recommendation by the Health and Human Services Department (HHS) to the Drug Enforcement Administration (DEA) regarding the

Weed Stocks Skyrocket, Could There Be More Upside? Analyst Draws Scenarios

The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's

Cannabis Tax Changes Could Trigger 504% Cash Flow Leap, Which Industry Players Will Benefit?

The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the

Rescheduling Cannabis: What Are The Implications For MSOs, Tax Rule 280E, FDA And Pharma?

The potential of rescheduling and removing Tax Rule 280E could boost profits for U.S. businesses. However, Zuanic and Associates' latest report reveals complexities and overlooked consequences.

MSOs And Cannabis Rescheduling: A Safer Bet? Analyst Looks Closer At Pros And Cons

Will the rescheduling of cannabis fuel a boom in cannabis stocks? Analysts from Z&A delve into the pros and cons of MSOs and cannabis rescheduling in their latest equity research report.

This Tax Break Could Reshape The Cannabis Landscape With A $700M Boost

Section 280e of the Internal Revenue Code has emerged as an unexpected catalyst, potentially injecting a staggering $700 million boost into cash flow for major cannabis companies.

Connecticut And Illinois Governors Support Cannabis Industry With Tax Relief Measures, Here's How

Connecticut and Illinois recently made significant moves to show their support for marijuana industries by enacting tax relief via their budget legislation.

Connecticut Lawmakers Pass Marijuana Tax Relief And Regulation Bills, Gov Lamont's Approval Expected

Connecticut lawmakers took a major step toward bolstering the state's marijuana industry by advancing two bills to Gov. Ned Lamont (D) for final approval.

New Jersey Gov Murphy Signs Law Relieving Cannabis Companies Of Punitive IRS Tax Code, Who's Next?

New Jersey Gov. Phil Murphy did the cannabis industry in his state a huge favor when he signed a law decoupling marijuana businesses from federal IRS Code Section 280E, the bane of the industry’s collective existence.

Cannabis Chart Of The Week: The Enormous Tax Impact On Marijuana Companies From IRS Code 280E